Efficacy and safety of aclidinium/formoterol versus monotherapies and aclidinium versus placebo in Chinese and other Asian patients with moderate-to-severe COPD: The AVANT Phase 3 study
Article in Respiratory Medicine (August 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Respiratory Medicine (August 2023)
Book chapter (June 2022)
Article in Chinese Critical Care Medicine (November 2021)